Media Releases

The technology transfer centre Swiss PIC will be located in the Park Innovaare.

Research scientists at PSI and ANAXAM use neutrons to look inside brake callipers and identify potential ways of reducing CO₂ emissions.

The PSI scientists Zurab Guguchia and Kirsten Schnorr are to receive grants totalling CHF 3.1 million from the Swiss National Science Foundation for ground-breaking projects.

Researchers are identifying and studying material compounds whose unique properties could lead to the development of novel types of chip.

Newly established Focal Biosciences will focus on bringing together leading experts and scientific discoveries to harness cellular reprogramming in the fight against common age-related diseases.

Unlocking the secrets of Zwischgold at PSI.

Improved method thanks to a molecular trick

The Paul Scherrer Institute PSI and the start-up AlphaSYNT are piloting a new approach for storing energy in the form of methane gas.

Researchers have shown that mirror-image substances – so-called enantiomers – can be better distinguished using helical X-ray light.

Researchers have measured and determined the sources of aerosol pollution at 22 locations in Europe.

New exhibition in the PSI Visitor Centre

PSI researchers have developed a new substance that disables a vital protein in the cell skeleton.

PSI researchers are the first to observe a specific behaviour of magnetic ice.

PSI develops a revolutionary achromatic lens for X-rays.

The test identifies different virus variants and improves disease prognosis.

In pursuit of particularly stable quantum bits, researchers have closely examined the electron distribution in two semiconductors.

PSI scientists have shed light on the structure of an important component of the eye: CNG ion channels whose job is to relay optical signals to the brain.

Boosted with superconductivity: Semiconductor technology can get a new twist by exploiting quantum effects in superconductors.

Kantonsspital Baden and the Paul Scherrer Institute PSI have signed a cooperation agreement.

Combining two chemotherapeutic drugs inhibits tumour growth.